ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "longitudinal studies"

  • Abstract Number: 647 • 2019 ACR/ARP Annual Meeting

    Is ANA-status at Disease Inception Associated with Long-term Damage Accrual and Direct and Indirect Health Care Costs in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort?

    May Choi1, Megan Barber 2, Marvin Fritzler 1, John G Hanly 3, Murray Urowitz 4, Yvan St-Pierre 5, Juanita Romero-Diaz 6, Caroline Gordon 7, Sang-Cheol Bae 8, Sasha Bernatsky 9, Daniel J Wallace 10, David A Isenberg 11, Anisur Rahman 12, Ellen M Ginzler 13, Michelle Petri 14, Ian Bruce 15, Paul Fortin 16, Dafna Gladman 17, Jorge Sanchez-Guerrero 18, Rosalind Ramsey-Goldman 19, Munther A Khamashta 20, Cynthia Aranow 21, Meggan Mackay 22, Graciela Alarcón 23, Susan Manzi 24, Ola Nived 25, Andreas Jönsen 25, Asad Zoma 26, Ronald van Vollenhoven 27, Manuel Ramos-Casals 28, Guillermo Ruiz-Irastorza 29, S Sam Lim 30, Kenneth C Kalunian 31, Murat Inanc 32, Diane Kamen 33, Christine Peschken 34, Soren Jacobsen 35, Anca Askanase 36, Vernon Farewell 37 and Ann E Clarke 38, 1Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 2University of Calgary, Calgary, Canada, 3Dalhousie University, Halifax, NS, Canada, 4University Health Network, University of Toronto, Toronto, ON, Canada, 5McGill University Health Centre, Montreal, QC, Canada, 6Instituto Nacional de Ciencias Medicas y Nutricion Salvador, Zubiran Vasco de Quiroga, Mexico City, Mexico, 7University of Birmingham, Birmingham, United Kingdom, 8Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea, 9Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 10Cedars-Sinai Medical Centre, Beverly Hills, CA, 11Centre for Rheumatology, London, United Kingdom, 12University College London, London, United Kingdom, 13State University of New York Downstate Medical Center, Brooklyn, NY, 14Johns Hopkins University School of Medicine, Baltimore, MD, 15University of Manchester, Manchester, United Kingdom, Manchester, England, United Kingdom, 16Division de Rhumatologie, Département de Médecine, CHU de Québec – Université Laval, Axe maladies infectieuses et inflammatoires, Centre de recherche du CHU de Québec – Université Laval, Canada, Quebec, QC, Canada, 17University of Toronto, Toronto, ON, Canada, 18Toronto Western Hospital, Toronto, ON, Canada, 19Northwestern University, Chicago, IL, 20King's College London School of Medicine, London, United Kingdom, 21Feinstein Institute for Medical Research, Manhasset, NY, 22Feinstein Institute for Medical Research, New York, 23University of Alabama at Birmingham, Birmingham, 24Allegheny Health Network, Pittsburg, PA, 25Lund University, Lund, Sweden, 26Hairmyres Hospital, East Kilbride, United Kingdom, 27Amsterdam Rheumatology and Immunology Center ARC, Amsterdam, the Netherlands, Amsterdam, Netherlands, 28Josep Font Autoimmune Diseases Laboratory, Barcelona, Spain, 29Autoimmune Diseases Unit, Hospital Universitario Cruces, Barakaldo, Spain, Barakaldo, Spain, 30Emory University, Atlanta, GA, 31UC San Diego School of Medicine, LaJolla, CA, 32Istanbul University, Istanbul, Turkey, 33Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., Charleston, SC, 34University of Manitoba, Winnipeg, Canada, 35Copenhagen Lupus and Vasculitis Clinic, Copenhagen, Denmark, 36Columbia University Medical Center, New York, NY, 37University of Cambridge, Cambridge, United Kingdom, 38University of Calgary, Calgary, AB, Canada

    Background/Purpose: We reported that 7.7% (88/1137) of patients in an international inception cohort were ANA-negative at enrolment (Arthritis Care Res 2018 doi:1002/acr23712).  There are no…
  • Abstract Number: 240 • 2018 ACR/ARHP Annual Meeting

    Bi-Directional Associations between “Too Much Sitting” and Self-Reported Pain in Patients with Rheumatoid Arthritis

    Ciara O'Brien1, Joan L. Duda1, Jet J.C.S. Veldhuijzen van Zanten1,2, George S. Metsios2,3, George D. Kitas1,2,4 and Sally A.M. Fenton1,2, 1School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, United Kingdom, 2Department of Rheumatology, Russells Hall Hospital, Dudley Group of Hospitals NHS Foundation Trust, Dudley, United Kingdom, 3Faculty of Education Health & Wellbeing, University of Wolverhampton, Walsall, United Kingdom, 4Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester, United Kingdom

    Background/Purpose: Epidemiological evidence indicates that sedentary behaviour, or “too much sitting”, is associated with poor health outcomes in the general population, including elevated systemic inflammation.…
  • Abstract Number: 455 • 2018 ACR/ARHP Annual Meeting

    Metabolic Syndrome and Trajectories of Pain Severity and Number of Painful Sites in Knee Osteoarthritis: Data from a 10.7-Year Prospective Study

    Feng Pan1, Jing Tian2, Flavia Cicuttini3 and Graeme Jones4, 1Musculoskeletal Unit, Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia, 2Public health unit, Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia, 3Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia, 4Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia

    Background/Purpose: Metabolic syndrome (MetS) has been suggested as having a role in osteoarthritis (OA) pathogenesis. No study has assessed whether MetS and its components are…
  • Abstract Number: 565 • 2018 ACR/ARHP Annual Meeting

    Genetic Polymorphism in Dihydrofolate Reductase Impacts Methotrexate Polyglutamation in Adult Rheumatoid Arthritis

    Thierry Dervieux1, Marie Grosjean2, Chuang Jiang3,4, Kelley Brady1, Kjeld Schmiegelow2, Joel Kremer5 and Jun Yang4, 1Exagen Diagnostics, Inc., Vista, CA, 2University Hospital Rigshospitalet, Copenhagen, Denmark, 3Shanghai Children’s Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai, China, 4Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN, 5Albany Medical College and The Center for Rheumatology, Albany, NY

    Background/Purpose: Methotrexate (MTX) is anti-folate activated to MTX polyglutamates (MTXPGs). MTX metabolism includes multiple enzyme-mediated reactions and genetic polymorphisms in these genes are linked to…
  • Abstract Number: 1179 • 2018 ACR/ARHP Annual Meeting

    Achieving Important Improvement in WOMAC Pain and Function By Three Months Post-Surgery Influences Satisfaction 1 Year Following Total Knee Replacement (TKR)

    Aileen Davis1, Selahadin Ibrahim2, Sheilah Hogg-Johnson3, Rosalind Wong4, Dorcas Beaton5, Bert Chesworth6, Rajiv Gandhi7, Nizar Mahomed8, Anthony V. Perruccio9, Vai Rajgopal10 and James Waddell11, 1Health Care and Outcomes Research, Krembil Research Institute, University Health Network, Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada, 2Institute for Work and Health, Toronto, ON, Canada, 3Canadian Memorial Chiropractic College, Toronto, ON, Canada, 4Krembil Research Institute, Health Care and Outcomes Research, Toronto, ON, Canada, 5University of Toronto, Department of Occupational Science and Occupational Therapy, Rehabilitation Sciences Institute, and the Institute for Health Policy Management and Evaluation, Toronto, ON, Canada, 6Western University, London, ON, Canada, 7Department of Surgery - Orthopedics, Toronto Western Hospital, Assistant Professor, Department of Surgery, University of Toronto​, Toronto, ON, Canada, 8Orthopaedics, University Health Network, Toronto, ON, Canada, 9Arthritis Program, Krembil Research Institute, University Health Network, Toronto, ON, Canada, 10Orthopaedics, Middle Sex Hospital Alliance, Strathroy, ON, Canada, 11Orthopaedics, Saint Michael's Hospital, Toronto, ON, Canada

    Background/Purpose: Understanding the impact of the time of achievement of important improvement (II) in pain and function may further understanding of outcome and inform care…
  • Abstract Number: 1851 • 2018 ACR/ARHP Annual Meeting

    Physical Function Trajectories in Children with Juvenile Myositis

    Kaveh Ardalan1, Elizabeth L. Gray2, Julia (Jungwha) Lee2, Madison L. Wolfe3, Gabrielle A. Morgan4 and Lauren M. Pachman5, 1Departments of Pediatrics and Medical Social Sciences, Division of Rheumatology, Northwestern University Feinberg School of Medicine/Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 2Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Creighton University School of Medicine, Omaha, NE, 4Cure JM Program of Excellence in Myositis Research, Stanley Manne Children’s Research Institute, affiliated with Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, 5Cure JM Program of Excellence in Juvenile Myositis Research, Stanley Manne Children’s Research Institute, affiliated with Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL

    Background/Purpose: Juvenile myositis (JM) is an inflammatory disease that causes muscle weakness, skin rashes, and significant deconditioning. Little is known about long-term resolution of physical…
  • Abstract Number: 1907 • 2018 ACR/ARHP Annual Meeting

    High Serum Adiponectin Associates with the Incidence of Rheumatoid Arthritis in Obese Subjects

    Cristina Maglio1, Yuan Zhang2, Christian Herder3, Anna Rudin4 and Lena Carlsson5, 1Dep. of Rheumatology and Inflammation Research and Wallenberg Centre for Molecular and Translational Medicine, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden, 2Dep. of Rheumatology and Inflammation Research, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden, 3German Diabetes Center, Düsseldorf, Germany, 4Dept of Rheumatology and Inflammation Research, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden, 5Department of Molecular and Clinical Medicine, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden

    Background/Purpose: Adiponectin, a cytokine mainly produced by the adipose tissue, plays an important role in several metabolic and inflammatory processes. In obese subjects, serum adiponectin…
  • Abstract Number: 1908 • 2018 ACR/ARHP Annual Meeting

    Bariatric Surgery Does Not Affect the Incidence of Rheumatoid Arthritis in Obese Subjects

    Yuan Zhang1, Cristina Maglio2, Anna Rudin3 and Lena Carlsson4, 1Dep. of Rheumatology and Inflammation Research, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden, 2Dep. of Rheumatology and Inflammation Research and Wallenberg Centre for Molecular and Translational Medicine, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden, 3Dept of Rheumatology and Inflammation Research, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden, 4Department of Molecular and Clinical Medicine, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden

    Background/Purpose: Obesity is among the risk factors for rheumatoid arthritis (RA). Bariatric surgery is an effective treatment to achieve weight loss and to prevent obesity-related…
  • Abstract Number: 2536 • 2018 ACR/ARHP Annual Meeting

    Vagus Nerve Stimulation in Patients with Rheumatoid Arthritis: 24 Month Safety and Efficacy

    Frieda A. Koopman1, Anne Musters2, Marieke M.J. Backer2, Danielle Gerlag2, Sanda Miljko3, Simeon Grazio4, Sekib Sokolovic5, Yaakov Levine6, David Chernoff6, Niek de Vries7 and Paul-Peter Tak2, 1Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 2Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 3University Clinical Hospital, Mostar, Bosnia, 4Vinogradsira 29, Clinical Hospital Center Sestre Milosrdnice, Zagreb, Croatia, 5Rheumatology, Sarajevo University Clinical Center, Sarajevo, BA, 6SetPoint Medical, Inc., Valencia, CA, 7Dept. of Experimental Immunology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands

    Background/Purpose: RA is a debilitating chronic disease with an unmet need for additional therapeutic approaches. Modulating innate neuro-immune reflex pathways by stimulation of the vagus…
  • Abstract Number: 2712 • 2018 ACR/ARHP Annual Meeting

    Evaluation of Longitudinal Outcomes in Scleroderma Patients with Negative Immunofluorescent Anti-Nuclear Antibodies

    Mayce Haj-Ali1, Derek Jones2, Sean McNish3, Sarah Stupp3, Marissa Mangini3 and Victoria Shanmugam4, 1Department of Medicince, The George Washington University School of Medicine and Health Sciences, Washington, DC, 2The George Washington University, Washington, DC, 3The George Washington University School of Medicine and Health Sciences, Washington, DC, 4Rheumatology, The George Washington University, Washington, DC

    Background/Purpose: Systemic Sclerosis (SSc) is an autoimmune disease characterized by inflammation, fibrosis, and vasculopathy. Historical data indicates approximately 90% of patients with SSc test positive…
  • Abstract Number: 2882 • 2018 ACR/ARHP Annual Meeting

    Minimal Progression of Disease Manifestation in Patients with Sjögren’s Syndrome Re-Evaluated Multiple Years after Initial Disease Classification

    Astrid Rasmussen1, Lida Radfar2, Kimberly Hefner3, David M. Lewis4, C. Erick Kaufman5, Donald U. Stone6, Kerry M. Leehan1, Kiely Grundahl7, Christopher J. Lessard1, A. Darise Farris8, R. Hal Scofield9 and Kathy L. Sivils10, 1Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Department of Oral Diagnosis and Radiology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 3Hefner Eye Care Center, Oklahoma City, OK, 4Department of Oral and Maxillofacial Pathology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 5Medicine, University of Oklahoam Health Sciences Center, Oklahoma City, OK, 6Ophthalmology, Johns Hopkins University, Baltimore, MD, 7Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma CIty, OK, 8Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 9Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 10Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: Classical connective tissue diseases, such as SLE and RA have well documented progression of disease and damage accrual. However, the natural history of Sjögren’s…
  • Abstract Number: 2966 • 2018 ACR/ARHP Annual Meeting

    Ultrasound Shows Rapid Reduction of Uric Load during Treat-to-Target Approach in Gout Patients: Results from a Longitudinal Study

    Hilde B Hammer1, Lars Fritjof Karoliussen2, Lene Terslev3, Espen A. Haavardsholm1, Tore Kvien4 and Till Uhlig5, 1Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Dept of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 3Rheumatology, Rigshospitalet Glostrup, Copenhagen, Denmark, 4RAID working group for EULAR, Zurich, Switzerland, 5Rheumatology, Diakonhjemmet Hospital, Oslo, Norway

    Background/Purpose:  Uric monosodium urate (MSU) depositions are detected by ultrasound (US), and US is included in the ACR/EULAR classification criteria for gout. OMERACT definitions for…
  • Abstract Number: 2946 • 2017 ACR/ARHP Annual Meeting

    Identifying Rapid Structural Disease Progression in Knee Osteoarthritis

    Jamie E. Collins1,2, Jeffrey N. Katz2,3 and Elena Losina1,2, 1Orthopaedic and Arthritis Center for Outcomes Research, Department of Orthopedic Surgery, Brigham & Women's Hospital, Boston, MA, 2Harvard Medical School, Boston, MA, 3Rheumatology, Immunology, and Allergy, Brigham & Women's Hospital, Boston, MA

    Background/Purpose:  Knee OA is a heterogeneous disease, with some patients experiencing rapid deterioration and others experiencing slow disease progression. Identifying patients likely to experience rapid…
  • Abstract Number: 330 • 2017 ACR/ARHP Annual Meeting

    Change in Bone Mineral Density in Patients with Rheumatoid Arthritis: Minimal 10-Year Follow-up

    Hiraku Motomura, Isao Matsushita, Toshihito Hiraiwa and Tomoatsu Kimura, Department of Orthopaedic Surgery, Faculty of Medicine, University of Toyama, Toyama, Japan

    Background/Purpose: To investigate the long-term change in bone mineral density (BMD) in patients with rheumatoid arthritis (RA). Methods: In a longitudinal study of 40 patients…
  • Abstract Number: 2957 • 2017 ACR/ARHP Annual Meeting

    Factors Associated with Cardiac Dysfunction in a Longitudinal Follow-up of Neonatal Lupus

    Amit Saxena1, Peter M. Izmirly2, Rebecca Bomar2, Shireen Golpanian2, Deborah Friedman3 and Jill P. Buyon1, 1Rheumatology, New York University School of Medicine, New York, NY, 2New York University School of Medicine, New York, NY, 3New York Medical College, Valhalla, NY

    Background/Purpose: There are minimal data and no longitudinal studies regarding the long term cardiac health of children with cardiac manifestations of neonatal lupus (NL). This…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 17
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology